Provides an international reference on clinical cancer medicine. It combines the experience of the world's leading cancer experts, particularly from leading European centres of excellence, with an approach that emphasizes the importance of the best clinical evidence: the guidelines to management are based on the sum of all the available evidence. For rare tumours, where clinical experience is the main guide to treatment, the editors have ensured that options and alternatives are discussed. There are major sections on all cancer sites, and in each section investigation, epidemiology, pathology, causes and treatment are covered in a consistent manner to aid reference. Quality-of-life and psychosocial issues, palliation, and communication are included.
Indice testuale
SECTION HEADINGS; MOLECULAR AND CELLULAR BIOLOGY OF CANCER; AETIOLOGY, EPIDEMIOLOGY, AND PREVENTION OF CANCER; DIAGNOSIS AND INVESTIGATIVE PROCEDURES; SCIENTIFIC BASIS OF CANCER TREATMENT; COMPLICATIONS OF CANCER; QUALITY OF LIFE AND PSYCHOSOCIAL ISSUES; ASSESSENT OF THE RESULTS OF CANCER TREATMENT; MELANOMA AND SKIN CANCER; HEAD AND NECK CANCER; GASTROINTESTINAL TUMOURS; BREAST CANCER; GYNAECOLOGICAL CANCER; UROLOGICAL CANCER; THORACIC TUMOURS; LYMPHOID AND MYELOID DYSPLASIA, HISTIOCYTOSIS AND AIDS-RELATED MALIGNANCY; BONE TUMOURS AND SOFT TISSUE SARCOMAS; PAEDIATRIC TUMOURS; TUMOURS OF THE CENTRAL NERVOUS SYSTEM; ENDOCRINE TUMOURS; TUMOURS OF UNKNOWN PRIMARY SITE
